May 23, 2012
Emory University is dedicated to facilitating Saint Joseph’s Translational Research Institute’s (SJTRI) mission to advance the development of innovative therapeutics by providing exceptional quality work to industry and academic collaborators in the biomedical research field. SJTRI will remain a world-class GLP compliant, AAALAC accredited facility. Emory has no plans to internalize the Institute, and SJTRI remains a separate non-profit entity operating under the Emory/Saint Joseph’s Joint Operating Company. You can learn more about SJTRI at www.sjtri.org.
SJTRI was restructured earlier this year to strengthen the organization financially and to make SJTRI strategically viable moving forward. We are focused on funded preclinical studies and education and training programs, and we will continue to carry out high-quality studies that result in FDA/CE mark approvals in areas such as cardiology and orthopaedics.
In order to facilitate collaboration between Emory and SJTRI, a favorable internal pricing program is being developed. If you are planning a preclinical study or working with a company to schedule an education event, please contact us to discuss how we can assist you. You can reach us by email at SJTRIemail@emoryhealthcare.org or by phone at (678) 843-6500.
Interim President at SJTRI
Assistant Vice President for Research and Real Estate at Emory University and its Robert W. Woodruff Health Sciences Center